The beauty capital deserves beauty-grade IV therapy
5mg per vial Potential For Patients seeking an alternative approach to appetite control, or those who may not tolerate GLP-1 medications well due to gastrointestinal side effects
10.1016/S0149-2918(03)80130-3 11
Yokoe M, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Gomi H, Pitt HA, Gouma DJ, Garden OJ, Buchler MW, Kiriyama S, Kimura Y, Tsuyuguchi T, Itoi T, Yoshida M, Miura F, Yamashita Y, Okamoto K, Gabata T, Hata J, Higuchi R, Windsor JA, Bornman PC, Fan ST, Singh H, de Santibanes E, Kusachi S, Murata A, Chen XP, Jagannath P, Lee S, Padbury R, Chen MF, Tokyo Guidelines Revision C (2012) New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines
Cancer micro-environment may also contribute to L-asparaginase resistance in leukemic blasts